HomeNewsCipla india

Cipla India

Jump to

Sanofi, Cipla seal exclusive distribution partnership to expand reach of CNS portfolio in India

Cipla will utilise its skills and solid network of distributors, institutions, and market outreach programmes to expand access to these treatments for patients, while Sanofi India will continue to own, import, and manufacture its entire range of CNS products across plants in India and abroad
Contamination risk among 8 FDA observations on Cipla, stock takes a hit

The US FDA’s current Good Manufacturing Practices (cGMP) inspection at the said unit was conducted between February 6 and February 17.
Shareholders to decide Cipla Medpro takeover on Wednesday

CNBC-TV18‘s Archana Shukla reports that shareholders will decide Cipla India‘s USD 510-million dollar offer to take over Cipla Medpro on Wednesday.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Cipla India

Sanofi, Cipla seal exclusive distribution partnership to expand reach of CNS portfolio in India

Contamination risk among 8 FDA observations on Cipla, stock takes a hit

Shareholders to decide Cipla Medpro takeover on Wednesday